Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CRM vs GSK✓SelectedUSD · GSKCRM vs GSK performance historyLatest closeAs of-1.47%11/20
Stock and ETF performance explorer

CRM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-38.0%
GSK return
+40.7%
Excess return
-78.6%
Maximum drawdown
-58.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.5%-0.1%-1.3%-1.5%
7D-17.1%-5.3%-11.8%-16.5%
30D-25.3%-3.7%-21.6%-25.0%
3M-11.9%-7.3%-4.7%-11.2%
6M+0.7%-4.2%+5.0%+1.1%
YTD-31.4%+0.9%-32.2%-32.2%
1Y-19.2%+7.3%-26.5%-21.1%
3Y-18.2%+52.7%-71.0%-27.2%
All-38.0%+40.7%-78.6%-49.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling